Zacks: Brokerages Expect Oak Street Health, Inc. (NYSE:OSH) Will Announce Quarterly Sales of $508.06 Million

Analysts predict that Oak Street Health, Inc. (NYSE:OSHGet Rating) will report sales of $508.06 million for the current fiscal quarter, Zacks reports. Eight analysts have made estimates for Oak Street Health’s earnings, with the lowest sales estimate coming in at $506.10 million and the highest estimate coming in at $512.70 million. Oak Street Health reported sales of $296.70 million during the same quarter last year, which indicates a positive year over year growth rate of 71.2%. The firm is scheduled to issue its next earnings results after the market closes on Monday, January 1st.

On average, analysts expect that Oak Street Health will report full-year sales of $2.13 billion for the current year, with estimates ranging from $2.12 billion to $2.17 billion. For the next year, analysts forecast that the business will post sales of $3.01 billion, with estimates ranging from $2.63 billion to $3.44 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Oak Street Health.

Oak Street Health (NYSE:OSHGet Rating) last posted its quarterly earnings data on Monday, February 28th. The company reported ($0.62) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.59) by ($0.03). Oak Street Health had a negative return on equity of 231.28% and a negative net margin of 28.57%. The company had revenue of $394.10 million during the quarter, compared to analyst estimates of $389.79 million. During the same period in the prior year, the firm earned ($0.40) earnings per share. Oak Street Health’s revenue was up 58.5% compared to the same quarter last year.

Several research firms have weighed in on OSH. Raymond James lowered their price target on Oak Street Health from $60.00 to $35.00 and set an “outperform” rating on the stock in a report on Tuesday, January 18th. Cowen upgraded Oak Street Health from a “market perform” rating to an “outperform” rating and raised their target price for the company from $25.00 to $30.00 in a research note on Thursday, March 17th. UBS Group started coverage on Oak Street Health in a research note on Wednesday, April 20th. They issued a “neutral” rating and a $26.00 target price for the company. Canaccord Genuity Group lowered their price objective on Oak Street Health from $49.00 to $29.00 in a research note on Wednesday, March 2nd. Finally, Piper Sandler reduced their target price on Oak Street Health from $47.00 to $43.00 and set an “overweight” rating for the company in a report on Wednesday, March 2nd. Five research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to, the stock currently has an average rating of “Buy” and an average target price of $39.79.

In other Oak Street Health news, insider Geoffrey M. Price sold 60,000 shares of the firm’s stock in a transaction dated Tuesday, April 19th. The shares were sold at an average price of $24.91, for a total transaction of $1,494,600.00. Following the completion of the transaction, the insider now owns 2,073,270 shares in the company, valued at $51,645,155.70. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Timothy M. Cook sold 1,514 shares of the business’s stock in a transaction that occurred on Friday, February 4th. The stock was sold at an average price of $16.66, for a total transaction of $25,223.24. The disclosure for this sale can be found here. Insiders sold a total of 233,271 shares of company stock valued at $5,695,945 over the last three months. Corporate insiders own 11.40% of the company’s stock.

A number of large investors have recently made changes to their positions in OSH. Cullen Frost Bankers Inc. bought a new stake in shares of Oak Street Health during the third quarter worth about $28,000. CI Investments Inc. purchased a new position in Oak Street Health during the 3rd quarter valued at about $28,000. Confluence Wealth Services Inc. purchased a new position in Oak Street Health during the 4th quarter valued at about $34,000. Canada Pension Plan Investment Board bought a new stake in shares of Oak Street Health in the fourth quarter worth approximately $46,000. Finally, Fifth Third Bancorp purchased a new position in Oak Street Health during the first quarter valued at approximately $46,000. 86.15% of the stock is currently owned by institutional investors and hedge funds.

Shares of NYSE:OSH opened at $18.09 on Friday. The company has a market capitalization of $4.36 billion, a PE ratio of -9.83 and a beta of 2.18. The company has a debt-to-equity ratio of 16.10, a current ratio of 2.06 and a quick ratio of 2.06. The business has a fifty day moving average price of $22.88 and a two-hundred day moving average price of $28.05. Oak Street Health has a 1 year low of $13.72 and a 1 year high of $65.22.

Oak Street Health Company Profile (Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

See Also

Get a free copy of the Zacks research report on Oak Street Health (OSH)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with's FREE daily email newsletter.